Skip to main content
. 2020 Jul 17;20(3):2623–2630. doi: 10.3892/etm.2020.9021

Figure 3.

Figure 3

Protein levels of IKKβ, p-IKKβ, IκBα, p-IκBα, p65 and p-p65 in the different treatment groups. (A) Western blotting was performed to assess the protein expression levels of p-IKKβ, p-IκBα, IKKβ, IκBα, p65, and p-p65. Densitometric analysis of western blotting for (B) IKKβ, (C) p-IKKβ/IKKβ, (D) IκBα, (E) p-IκBα/IκBα, (F) p65 and (G) p-p65/p65. #P<0.05 vs. the control group. *P<0.05 vs. the IL-1β group. IKKβ, inhibitor of NF-κβ-β; p, phosphorylated; IκBα, NF-κβ inhibitor α; IL, interleukin; AG, aminoguanidine.